Ergebnisse einer randomisierten Phase-III-Studie zur Behandlung rezidivierter Glioblastome: NovoTTF-100A versus Chemotherapie

Author: Nieder C.  

Publisher: Springer Publishing Company

ISSN: 0179-7158

Source: Strahlentherapie und Onkologie, Vol.189, Iss.1, 2013-01, pp. : 93-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content